Glycopeptides (FSH, LH, TSH, Prolactin) and Glycoproteins in Patients with Genitourinary Cancer
- 1 January 1981
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 38 (2) , 110-115
- https://doi.org/10.1159/000225533
Abstract
The present investigation has analyzed 249 patients suffering from urogenital cancer in respect to aberrant concentration of prolactin, TSH, LH and FSH. A simultaneous pattern of acute phase reactants (α1 glycoprotein, α1-antitrypsin, β2-glycoprotein and haptoglobin) was related to the content of these hormones. Abnormal results of prolactin and TSH were present in 30% of all patients, whereas frequent aberrations of α1-acid glycoprotein and α1-antitrypsin were detected in 60–80%. Acute phase reactants changed to more pathological values when correlated to elevated prolactin.Keywords
This publication has 7 references indexed in Scilit:
- Aberrant Peptide Hormones in Patients with Urogenital CarcinomasEuropean Urology, 1979
- Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma. A prospective studyCancer, 1978
- CELL-PROLIFERATION KINETICS AND NUCLEAR MORPHOLOGY IN ENDOMETRIAL CANCER UNDER PROGESTERON TREATMENT1978
- Endocrine studies in testicular tumor patients with and without gynecomastia.A report of 45 casesCancer, 1978
- Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymesBritish Journal of Cancer, 1977
- Ectopic Production of Human Chorionic Gonadotrophin by NeoplasmsAnnals of Internal Medicine, 1973
- SERUM GLYCOPROTEINS: THEIR ORIGIN AND SIGNIFICANCEAnnals of the New York Academy of Sciences, 1961